Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M24,852Revenue (TTM) $M1,106Net Margin (%)9.4Altman Z-Score11.3
Enterprise Value $M24,695EPS (TTM) $0.5Operating Margin %13.1Piotroski F-Score6
P/E(ttm)248Beneish M-Score-1.5Pre-tax Margin (%)9.7Higher ROA y-yY
Price/Book59.110-y EBITDA Growth Rate %--Quick Ratio3.6Cash flow > EarningsY
Price/Sales23.05-y EBITDA Growth Rate %--Current Ratio3.6Lower Leverage y-yY
Price/Free Cash Flow138y-y EBITDA Growth Rate %102ROA % (ttm)7.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)35.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M189ROIC % (ttm)70.7Gross Margin Increase y-yN

Gurus Latest Trades with INCY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

INCY is held by these investors:



INCY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Huber Reid MEVP, Chief Scientific Officer 2017-01-09Sell11,739$113.5515.55view
SWAIN PAULA JEVP, Human Resources 2016-11-15Sell10,000$103.2627.07view
Huber Reid MEVP, Chief Scientific Officer 2016-11-09Sell2,715$109.9519.34view
SWAIN PAULA JEVP, Human Resources 2016-10-20Sell10,000$9045.79view
Huber Reid MEVP, Chief Scientific Officer 2016-10-07Sell11,709$96.436.11view
Flannelly Barry PEVP & General Manager US 2016-10-07Sell24,204$9735.27view
SWAIN PAULA JEVP, Human Resources 2016-09-23Sell20,000$9045.79view
Huber Reid MEVP, Chief Scientific Officer 2016-08-02Sell10,000$87.9649.17view
SWAIN PAULA JEVP, Human Resources 2016-07-29Sell60,000$9045.79view
BAKER JULIANDirector, 10% Owner 2016-03-17Buy800,000$63.98105.08view

Quarterly/Annual Reports about INCY:

News about INCY:

Articles On GuruFocus.com
Andreas Halvorsen Buys Maker of First-in-Class Cancer Treatments, Calithera Biosciences Feb 22 2017 
Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary Jan 24 2017 
Vanguard Health Care Fund Ups Stake in High-Conviction Stocks May 10 2016 
Market-Beating Vanguard Health Care Fund Adds Shares to 5 Positions May 03 2016 
Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 
Frank Sands Acquires Stake in Netflix Feb 23 2016 
Top Insider Trades of the Past Week Feb 19 2016 
The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings Nov 04 2015 
Amazon Among Ken Fisher's Best Performing Stocks Oct 19 2015 
Weekly CFO Sells Highlight: Aramark, Incyte Corp Ltd., Facebook Inc. Jun 09 2014 

More From Other Websites
Pharma company Incyte is moving to the S&P 500, and the stock is rallying Feb 24 2017
Incyte, University of Pennsylvania In Cancer Deal Feb 24 2017
Biotech Movers: Cempra Flys High On Phase Three Results Feb 24 2017
Incyte, CBOE Holdings, Regency Centers Set to Join S&P 500; Others to Join S&P MidCap 400 Feb 23 2017
Incyte Announces Oncology Research Alliance with the Abramson Cancer Center at the University of... Feb 23 2017
Andreas Halvorsen Buys Maker of First-in-Class Cancer Treatments, Calithera Biosciences Feb 22 2017
Incyte to Present at Upcoming Investor Conferences Feb 21 2017
INCYTE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... Feb 21 2017
INCYTE CORP Financials Feb 18 2017
Merck, Bristol-Myers, Incyte Race For A Cure In $25 Billion I-O Market Feb 17 2017
NetEase Delivers Nice Option Win; Mobileye, Tesla, InterDigital On Deck Feb 17 2017
Incyte Corp. :INCY-US: Earnings Analysis: 2016 By the Numbers : February 16, 2017 Feb 16 2017
Additional results from pivotal RA-BEAM study published in New England Journal of Medicine show... Feb 15 2017
Additional results from pivotal RA-BEAM study published in New England Journal of Medicine show... Feb 15 2017
Softness in Incyte Should Be Short-Lived, if Our Quants Are Right Feb 15 2017
Incyte's (INCY) Beats on Q4 Earnings, Provides 2017 Outlook Feb 15 2017
Incyte Corp. :INCY-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017 Feb 15 2017
Biotech Stock Roundup: Regeneron's Praluent to Remain on Market for Now, GILD Presents HIV Data Feb 15 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)